AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Home > Products > Xedexo

Product List

Xedexo

Generic:

Olanzapine, Fluoxetine
 

Therapeutic Class:

Psycholeptic Antidepressant

 

Composition:

  • Xedexo Cap 3 mg/ 25 mg: Each capsule contains 3 mg Olanzapine with 25 mg Fluoxetine.
  • Xedexo Cap 6 mg/ 25 mg: Each capsule contains 6 mg Olanzapine with 25 mg Fluoxetine.
 

Description:

Xedexo contains Olanzapine and Fluoxetine an atypical antipsychotic and a selective serotonin reuptake inhibitor.

 

Indications:

• Acute depressive episodes in Bipolar I Disorder
• Treatment resistant depression (Major Depressive Disorder in patient who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode)

Dosage:

Depressive Episodes Associated with Bipolar I Disorder:

Adults: One capsule daily in the evening, generally beginning with the 6 mg/25 mg capsule.

Children and adolescents (10 to 17 years of age):  One capsule daily in the evening, generally beginning with the 3 mg/25 mg capsule.

 

 Treatment Resistant Depression:

Administer one capsule daily in the evening, generally beginning with the 6 mg/25 mg capsule. Adjust dosage, if indicated, according to efficacy and tolerability.

Presentations:

  • Xedexo Cap 3 mg/25 mg & 6 mg/25 mg are available in pack of 14’s